Skip to main content
Search
Search
Quick Search anywhere
Quick Search anywhere
Quick Search anywhere
Quick Search anywhere
Quick Search anywhere
Quick Search anywhere
Advanced Search
Skip main navigation
No Access

Sourcing knowledge: R&D outsourcing in UK pharmaceuticals

Published Online:June 14, 2012pp 139-161https://doi.org/10.1504/IJTM.2012.047253

Abstract

The outsourcing of research and development (R&D) activities has grown rapidly in recent years. Outsourcing has major implications for how knowledge and R&D activities are organised and coordinated in a wider open innovation environment and creates major challenges for firms and their managers. This paper explores the implications of outsourcing and the increasingly distributed nature of research and innovative activities using primary survey data collected from the UK pharmaceutical industry. These issues are uniquely examined at both firm and activity level. This paper then seeks to set the findings of the study within the context of the wider debate and conceptual frameworks surrounding R&D outsourcing and offshoring in terms of the increasingly open and distributed nature of research operations. This paper concludes by exploring the implications for this for firm strategy and the open innovation agenda and for future research in this field.

Keywords

R&D outsourcing, pharmaceuticals research, UK, knowledge management

References

  • 1. Alchian, A.A. , Demsetz, H. (1972). ‘Production, information costs and economic organization’. American Economic Review. 62, 5, 777-795 Google Scholar
  • 2. Allarakhia, M. , Walsh, S. (2011). ‘Managing knowledge assets under conditions of radical change: the case of the pharmaceutical industry’. Technovation. 31, 2–3, 105-117 Google Scholar
  • 3. Amiti, M. , Wei, S-J. (2005). ‘Fear of service outsourcing: is it justified?’. Economic Policy. 20, 42, 308-347 Google Scholar
  • 4. Arora, A. , Gambardella, A. (1990). ‘Complementarity and external linkages: the strategies of the large firms in biotechnology’. Journal of Industrial Economics. 38, 4, 361-379 Google Scholar
  • 5. Arrow, K.J. , Nelson, R. (1962). ‘Economic welfare and the allocation of resources for inventions’. The Rate and Direction of Inventive Activity. Princeton:Princeton University Press , 609-625 Google Scholar
  • 6. Bianchi, M. , Cavaliere, A. , Chiaroni, D. , Frattini, F. , Chiesa, V. (2011). ‘Organisational modes for Open Innovation in the bio-pharmaceutical industry: an exploratory analysis’. Technovation. 31, 1, 22-33 Google Scholar
  • 7. Bierly, P. , Chakrabarti, A. (1996). ‘Generic knowledge strategies in the US pharmaceutical industry’. Strategic Management Journal. 17, Winter Special Issue, 123-135 Google Scholar
  • 8. Binns, R. , Driscoll, B. (1998). ‘Intellectual property issues in R&D contracts’. Pharmaceutical Sciences and Technology Today. 1, 3, 95-99 Google Scholar
  • 9. Carter, A.P. (1989). ‘Know-how trading as economic exchange’. Research Policy. 18, 3, 155-163 Google Scholar
  • 10. Casella, G. (1983). ‘Leverage and regression through the origin’. The American Statistician. 37, 2, 147-152 Google Scholar
  • 11. Cavusgil, S.T. , Calantone, R.J. , Zhao, Y. (2003). ‘Tacit knowledge transfer and firm innovation capability’. Journal of Business & Industrial Marketing. 18, 1, 6-21 Google Scholar
  • 12. Chesbrough, H. (2003). ‘The era of open innovation’. MIT Sloan Management Review. 44, 3, 35-41 Google Scholar
  • 13. Choi, C.Q. (2008). ‘Shire pharmaceuticals: a study in exponential growth’. The Scientist. 22, 1, 58 Google Scholar
  • 14. Cohen, W.M. , Levinthal, D.A. (1990). ‘Absorptive capacity: a new perspective on learning and innovation’. Administrative Science Quarterly. 35, 1, 128-152 Google Scholar
  • 15. Contractor, F.J. , Lorange, P. (2002). Cooperative Strategies and Alliances. Oxford:Pergamon , 493-516 Google Scholar
  • 16. Contractor, F.J. , Kumar, V. , et al. (2010). ‘Reconceptualizing the firm in a world of outsourcing and offshoring: the organizational and geographical relocation of high-value company functions’. Journal of Management Studies. 47, 8, 1417-1433 Google Scholar
  • 17. Della Valle, F. , Gambardella, A. (1993). ‘Biological revolution and strategies for innovation in pharmaceutical companies’. R&D Management. 23, 4, 287-302 Google Scholar
  • 18. DiMasi, J.A. , Hansen, R.W. , Grabowski, H.G. (2003). ‘The price of innovation: new estimates of drug development costs’. Journal of Health Economics. 22, 2, 151-185 Google Scholar
  • 19. Doctor, R.N. , Newton, D.P. , Pearson, A. (2001). ‘Managing uncertainty in research and development’. Technovation. 21, 2, 79-90 Google Scholar
  • 20. Domberger, S. (1998). The Contracting Organization: A Strategic Guide to Outsourcing. Oxford:Oxford University Press Google Scholar
  • 21. Easterby-Smith, M. , Lyles, M.A. , Tsang, E.W.K. (2008). ‘Inter-organizational knowledge transfer: current themes and future prospects’. Journal of Management Studies. 45, 4, 677-690 Google Scholar
  • 22. Eisenhauer, J.G. (2003). ‘Regression through the origin’. Teaching Statistics. 25, 3, 76-80 Google Scholar
  • 23. Enkel, E. , Gassmann, O. , Chesborough, H. (2009). ‘Open R&D and open innovation: exploring the phenomenon’. R&D Management. 39, 4, 311-316 Google Scholar
  • 24. Ford, D. , Farmer, D. (1986). ‘Make or buy – a key strategic issue’. Long Range Planning. 19, 5, 54-62 Google Scholar
  • 25. Freeman, C. , Soete, L. (1997). The Economics of Industrial Innovation. 3rd ed., London:Pinter Google Scholar
  • 26. Gabrowsky, H. , Kyle, M. , Gugler, K. Yurtoglu, B.B. (2008). ‘Mergers and alliances in pharmaceutical: effects on innovation and R&D productivity’. The Economics of Corporate Governance and Mergers. Edward Elgar Google Scholar
  • 27. Galambos, L. , Sturchio, J. (1996). ‘The pharmaceutical industry in the twentieth century: a reappraisal of the sources of innovation’. History and Technology. 13, 2, 83-100 Google Scholar
  • 28. Gassmann, O. , Reepmeyer, G. (2005). ‘Organizing pharmaceutical innovation: from science-based knowledge creators to drug-oriented knowledge brokers’. Creativity and Innovation Management. 14, 3, 233-245 Google Scholar
  • 29. Gassmann, O. , Enkel, E. , Chesborough, H. (2010). ‘The future of open innovation’. R&D Management. 40, 3, 213-221 Google Scholar
  • 30. Graves, S. , Langowitz, N. (1993). ‘Innovative productivity and returns to scale in the pharmaceutical industry’. Strategic Management Journal. 14, 8, 593-605 Google Scholar
  • 31. Grimpe, C. , Kaiser, U. (2010). ‘Balancing internal and external knowledge acquisition: the gains and pains from R&D outsourcing’. Journal of Management Studies. 47, 8, 1483-1509 Google Scholar
  • 32. Groenewegen, P. , Wouters, P. (2004). ‘Genomics, ICT and the formation of R&D networks’. Genetics and Society. 23, 2, 167-185 Google Scholar
  • 33. Grossman, G.M. , Helpman, E. (2005). ‘Outsourcing in a global economy’. Review of Economic Studies. 72, 1, 135-159 Google Scholar
  • 34. Hatonen, J. , Eriksson, T. (2009). ‘30+ years of research and practice of outsourcing – exploring the past and anticipating the future’. Journal of International Management. 15, 2, 142-155 Google Scholar
  • 35. Higgins, M.J. , Rodriguez, D. (2006). ‘The outsourcing of R&D through acquisitions in the pharmaceutical industry’. Journal of Financial Economics. 80, 2, 351-383 Google Scholar
  • 36. Howells, J. (1999a). ‘Research and technology outsourcing’. Technology Analysis & Strategic Management. 11, 1, 591-603 Google Scholar
  • 37. Howells, J. (1999b). ‘Research and technology outsourcing and innovation systems: an exploratory analysis’. Industry and Innovation. 6, 1, 111-129 Google Scholar
  • 38. Howells, J. (2002). ‘Mind the gap: information and communication technologies, knowledge activities and innovation in the pharmaceutical industry’. Technology Analysis & Strategic Management. 14, 3, 335-370 Google Scholar
  • 39. Howells, J. , Neary, I. (1995). Intervention and Technological Innovation: Government and the Pharmaceutical Industry in the UK and Japan. London:Macmillan Google Scholar
  • 40. Howells, J. , Gagliardi, D. , Malik, K. (2008). ‘The growth and management of R&D outsourcing: evidence from UK pharmaceuticals’. R&D Management. 38, 2, 205-219 Google Scholar
  • 41. Jones, O. (2000). ‘Innovation management as a post-modern phenomenon: the outsourcing of pharmaceutical R&D’. British Journal of Management. 11, 4, 341-356 Google Scholar
  • 42. Kay, N.M. (1984). The Boundaries of the Firm: Critiques, Strategies and Policies. London:Macmillan Google Scholar
  • 43. Kim, C. , Beldona, S. , Contractor, F.J. (2007). ‘Alliance and technology networks: an empirical study on technology learning’. International Journal of Technology Management. 38, 1/2, 29-44 Google Scholar
  • 44. Lenox, M. , King, A. (2004). ‘Prospects for developing absorptive capacity through internal information provision’. Strategic Management Journal. 25, 4, 331-345 Google Scholar
  • 45. Liebenau, J.M. (1984). ‘International R&D in pharmaceutical firms in the early twentieth century’. Business History. 26, 3, 329-346 Google Scholar
  • 46. Loveday, D.E.E. (1985). ‘Managing change in pharmaceutical industry R&D’. Technovation. 3, 2, 89-109 Google Scholar
  • 47. Madhavan, R. , Koka, B.R. , Prescott, J.E. (1998). ‘Networks in transition: how industry events (re)shape interfirm relationships’. Strategic Management Journal. 19, 5, 439-459 Google Scholar
  • 48. Martínez-Noya, A. , García-Canal, E. (2011). ‘Technological capabilities and the decision to outsource/outsource offshore R&D services’. International Business Review. 20, 3, 264-277 Google Scholar
  • 49. Massini, S. , Lewin, A.Y. , Numagami, T. , Pettigrew, A.M. (2002). ‘The evolution of organisational routines among large Western and Japanese firms’. Research Policy. 31, 8–9, 1333-1348 Google Scholar
  • 50. McKelvey, M. (1995). Evolutionary Innovation: The Business of Biotechnology. Oxford:Oxford University Press Google Scholar
  • 51. McMillan, G.S. , Hamilton, D. (2000). ‘Using bibliometrics to measure firm knowledge: an analysis of the US pharmaceutical industry’. Technology Analysis & Strategic Management. 12, 4, 465-475 Google Scholar
  • 52. Mikkola, J.H. (2003). ‘Modularity, component outsourcing, and inter-firm learning’. R&D Management. 33, 4, 439-454 Google Scholar
  • 53. Mowery, D.C. (1984). ‘Firm structure, government policy, and the organization of industrial research: Great Britain and the United States, 1900–1950’. Business History Review. 58, 4, 504-531 Google Scholar
  • 54. Mudambi, S.M. , Tallman, S. (2010). ‘Make, buy or ally? Theoretical perspectives on knowledge process outsourcing through alliances’. Journal of Management Studies. 47, 8, 1434-1456 Google Scholar
  • 55. Nightingale, P.L. (2000). ‘Economies of scale in experimentation: knowledge and technology in pharmaceutical R&D’. Industrial and Corporate Change. 9, 2, 315-359 Google Scholar
  • 56. Odagiri, H. (2003). ‘Transaction costs and capabilities as determinants of the R&D boundaries of the firm: a case study of the ten largest pharmaceuticals firms in Japan’. Managerial and Decision Economics. 24, 2–3, 187-211 Google Scholar
  • 57. OECD (2002). Frascati Manual: Standard Method Proposed for Surveys of Experimental Research and Development. Paris:OECD Google Scholar
  • 58. Office for National Statistics (ONS) (2007). Research and Development in UK Businesses 2005. Norwich:Business Monitor (MA14), HMSO Google Scholar
  • 59. Orsenigo, L. , Pammolli, F. , Riccaboni, M. (2001). ‘Technological change and network dynamics: lessons from the pharmaceutical industry’. Research Policy. 30, 3, 485-508 Google Scholar
  • 60. Pérez-Nordtvedt, L. , Kedia, B.L. , Datta, D.K. , Rasheed, A.A. (2008). ‘Effectiveness and efficiency of cross-border knowledge transfer: an empirical examination’. Journal of Management Studies. 45, 4, 714-744 Google Scholar
  • 61. Piachaud, B.S. (2002). ‘Outsourcing in the pharmaceutical manufacturing process: an examination of the CRO experience’. Technovation. 22, 2, 81-90 Google Scholar
  • 62. Pisano, G.P. (1990). ‘The R&D boundaries of the firm: an empirical analysis’. Administrative Science Quarterly. 35, 1, 153-176 Google Scholar
  • 63. Pisano, G.P. (1994). ‘Knowledge, integration and the locus of learning: an empirical analysis of process development’. Strategic Management Journal. 15, S1, 85-100 Google Scholar
  • 64. Powell, W.W. (1998). ‘Learning from collaboration: knowledge and networks in the biotechnology and pharmaceutical industries’. California Management Review. 40, 3, 228-240 Google Scholar
  • 65. Quinn, J.B. (1999). ‘Strategic outsourcing: leveraging knowledge capabilities’. Sloan Management Review. 40, 4, 9-21 Google Scholar
  • 66. Sanderson, M. (1972). ‘Research and the firm in British industry, 1919–39’. Social Studies of Science. 2, 2, 107-151 Google Scholar
  • 67. Sen, A. , MacPherson, A. (2009). ‘Outsourcing, external collaboration, and innovation among US firms in the biopharmaceutical industry’. Industrial Geographer. 6, 1, 20-36 Google Scholar
  • 68. Sen, A.K. (2009). ‘Outsourcing of research and development activities: evidence from U.S. biopharmaceutical firms’. Global Journal of Business Research. 3, 1, 73-82 Google Scholar
  • 69. Studt, T. ‘Knowledge management is key to improving drug R&D cycles’. R&D Magazine. 2003, 04, 18 Google Scholar
  • 70. Sutcliffe, K.M. , Zaheer, A. (1998). ‘Uncertainty in the transaction environment: an empirical test’. Strategic Management Journal. 19, 1, 1-23 Google Scholar
  • 71. Thomke, S. , Kuemmerle, W. (2002). ‘Asset accumulation, interdependence and technological change: evidence from pharmaceutical drug discovery’. Strategic Management Journal. 23, 7, 619-635 Google Scholar
  • 72. Tsai, W. (2001). ‘Knowledge transfer in intraorganizational networks: effects of network position and absorptive capacity on business unit innovation and performance’. Academy of Management Journal. 44, 5, 996-1040 Google Scholar
  • 73. Ulset, S. (1996). ‘R&D outsourcing and contractual governance: an empirical study of commercial R&D projects’. Journal of Economic Behaviour & Organization. 31, 1, 63-82 Google Scholar
  • 74. Walsh, V. , Niosi, J. , Mustar, P. (1995). ‘Small-firm formation in biotechnology: a comparison of France, Britain and Canada’. Technovation. 15, 5, 303-327 Google Scholar
  • 75. Welch, J.A. , Nayak, P.R. (1992). ‘Strategic sourcing: a progressive approach to the make-or-buy decision’. Academy of Management Executive. 6, 1, 23-31 Google Scholar
Previous article